Review | Open Access
Mini liver organoid models emulating metabolic dysfunction-associated steatotic disease development: gradually emerging beneath the iceberg
Views: 8
Metab Target Organ Damage. 2025;5:[Accepted].
Author Information
Article Notes
Cite This Article
Abstract
Tissue spatial interaction in the liver, including the interplay among immune cells, blood vessels, sinusoidal endothelial cells, bile ducts, stellate cells, hepatic progenitor cells, and hepatocytes, is crucial not only for normal organogenesis but also for disease development. Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the most prevalent liver disease, with heterogeneous mechanisms involving crosstalk between hepatocytes and stromal cells under metabolic stress, inflammation, and fibrosis. Developing 3D coculture liver organoid platforms provides novel insights into the complex links of cell communication during disease progression. Thus, we recapitulate liver organoids as models for indicating reconstructed inter-tissue interactions of MASLD, highlighting the potential of transplanting liver organoids as a therapeutic application.
Keywords
MASLD, liver organoid, 3D coculture, disease progression
Cite This Article
Feng T, Li J, Ma X, Ye J. Mini liver organoid models emulating metabolic dysfunction-associated steatotic disease development: gradually emerging beneath the iceberg. Metab Target Organ Damage. 2025;5:[Accept]. http://dx.doi.org/10.20517/mtod.2024.105
Copyright
© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

See Updates
Hot Topics
metabolic syndrome | kidney | atherosclerosis | endocrine disorder | NAFLD | diabetes | MAFLD | adipose tissue | obesity | obesity | metabolism | fatty liver | steatosis | fibrosis | cardiovascular | insulin resistance | hypertension | metabolomics | precision medicine | hypertriglyceridemia |